Masonic Cancer Center at University of Minnesota
425 E River Pkwy # 754
Minneapolis, Minnesota 55455
612-624-2620 http://www.cancer.umn.edu/

Use our guide to learn which trials are right for you!

Site Overview

The Masonic Cancer Center was founded in 1991. It is part of the University's Academic Health Center, which also includes the Medical School, School of Dentistry, School of Nursing, College of Pharmacy, School of Public Health and College of Veterinary Medicine. The Masonic Cancer Center's research partners include the University's Stem Cell Institute, Center for Immunology, and the Center for Magnetic Resonance Imaging; and its clinical research and treatment partners include the University of Minnesota Physicians; University of Minnesota Medical Center, Fairview; and University of Minnesota Amplatz Children's Hospital.

We've found
45 trials
at this facility
Endocrinology, Hematology, Neurology, Pharmacology / Toxicology, Rheumatology, Other Clinical Trial
MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematologic Malignancies Clinical Trial
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haploidentical Related Hematopoietic
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Malignant Solid Tumour Clinical Trial
Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Patients With Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fanconi Anemia Clinical Trial
Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Exemestane in Post-Menopausal Women With NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Muscle Invasive Bladder Cancer Clinical Trial
BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Allogeneic HCT Survivors Clinical Trial
Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
Status: Enrolling, Phase
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Smoking Clinical Trial
Trial of Indole-3-Carbinol and Silibinin
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
T Cell Receptor α/β TCD HCT in Patients With Fanconi Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia
Status: Enrolling
Updated: 10/11/2012
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Sarcoma Clinical Trial
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Status: Enrolling, Phase III
Updated: 6/23/2014
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Status: Enrolling, Phase I
Updated: 1/29/2014
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
Status: Enrolling, Phase
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Auto Stem Cell Transplant for Lymphoma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Leukemia Clinical Trial
Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Status: Enrolling
Updated: 7/12/2012
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive Clinical Trial
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Neuroblastoma Clinical Trial
High Dose Chemotherapy and Autologous Transplant for Neuroblastoma
Status: Enrolling
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Allo HSCT Using RIC for Hematological Diseases
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Graft vs Host Disease Clinical Trial
Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
Status: Enrolling
Updated: 4/10/2010
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Juvenile Myelomonocytic Leukemia Clinical Trial
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Childhood Langerhans Cell Histiocytosis Clinical Trial
Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 12/6/2011
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/3/2011
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Status: Enrolling, Phase I
Updated: 10/11/2012
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Fanconi Anemia Clinical Trial
Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Oncology Clinical Trial
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
Status: Enrolling, Phase
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CD16/IL-15/CD33 Tri-Specific Killer Engagers (TriKEs) for High Risk Heme Malignancies
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials